Sep. 17 at 2:02 PM
$MNKD $UTHR MannKind closed September 16 at
$3.55, giving it a market capitalization of approximately
$1.14 billion. A recent SEC filing reports roughly 321.5 million MNKD shares outstanding, which independently gives about
$1.14 billion at
$3.55/share.
United Therapeutics reported
$3.803 billion of cash, cash equivalents and marketable investments as of June 30.
So, at market price:
$1.14B ÷
$3.803B = 30.0%
In other words, MannKind’s entire current equity market capitalization is only about 30% of UTHR’s cash and investments.
